Cytokinetics, Incorporated

Q3 2024 13F Holders

Symbol
CYTK
CUSIP
23282W605
Type
Equity
Class
COM NEW
Num filings
408
Total reported value, excl. options
$7.28 B
Manager Report Date Value ($000) Shares Option Type